Caribou Biosciences, Inc. (CRBU)

NASDAQ: CRBU · Real-Time Price · USD

1.520

-0.070 (-4.40%)

At close: Feb 12, 2026, 4:00 PM EST

1.520

0.00 (0.00%)

Pre-market: Feb 13, 2026, 4:53 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Allogeneic Chimeric Antigen Receptor - T Cell Therapies	9.99M
Allogeneic Chimeric Antigen Receptor - T Cell Therapies Growth	-71.01%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.